CA9
CA9 (carbonic anhydrase 9, also known as CAIX or MN) is a transmembrane zinc metalloenzyme of the alpha-carbonic anhydrase family. It catalyses the interconversion of carbon dioxide and water with bicarbonate and hydrogen ions, and is one of only two tumour-associated carbonic anhydrase isoenzymes known. Browse Assay Genie's current range of CA9 research reagents below, or read on for the biology behind the target.
CA9 catalyses the interconversion between carbon dioxide and water and the dissociated ions of carbonic acid, namely bicarbonate and hydrogen ions. Like other carbonic anhydrases, it is a zinc metalloenzyme that drives the reversible hydration of carbon dioxide. The family as a whole participates in respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humour, cerebrospinal fluid, saliva and gastric acid.
The CA9 gene encodes a transmembrane protein that belongs to the alpha-carbonic anhydrase family. UniProt records it at the cell membrane, including the microvillus membrane, and also in the nucleus and nucleolus. Carbonic anhydrases show extensive diversity in tissue distribution and subcellular localisation. CA9 is expressed in all clear-cell renal cell carcinoma, yet it is not detected in normal kidney or most other normal tissues. This restricted pattern is why it is studied as a tumour-associated isoenzyme, and it may be involved in cell proliferation and transformation.
The protein is also called carbonic anhydrase IX (CA IX, CAIX) and MN, and HGNC places the gene in the carbonic anhydrases group. The mouse ortholog is Ca9. Early mapping work gave conflicting results: fluorescence in situ hybridisation suggested 17q21.2, whereas radiation hybrid mapping placed the gene at 9p13-p12. Researchers studying a CA9 antibody, CA9 ELISA kit or recombinant CA9 protein workflow will often compare it with other carbonic anhydrase isoenzymes.
CA9 is one of only two known tumour-associated carbonic anhydrase isoenzymes, making it a focus for studies of cancer-linked enzyme expression.
CA9 is expressed in all clear-cell renal cell carcinoma but not in normal kidney, which makes it a point of interest in kidney cancer studies.
As a catalyst of reversible carbon dioxide hydration, CA9 is relevant to studies of bicarbonate and hydrogen ion balance.
CA9 may be involved in cell proliferation and transformation, supporting investigation of how enzyme activity relates to growth control.
CA9 is a zinc metalloenzyme that catalyses the interconversion of carbon dioxide and water with bicarbonate and hydrogen ions. It is a transmembrane protein of the alpha-carbonic anhydrase family and may be involved in cell proliferation and transformation.
CA9 is also written CAIX, MN, or carbonic anhydrase IX (CA IX), the last being its previous HGNC name. The current approved name is carbonic anhydrase 9. These names refer to the same gene and protein, so check all of them when searching the literature.
CA9 is one of only two known tumour-associated carbonic anhydrase isoenzymes. It is expressed in all clear-cell renal cell carcinoma but not detected in normal kidney or most other normal tissues. A mouse ortholog, Ca9, exists; check the datasheet of any product for its validated reactivity.
Other carbonic anhydrase isoenzymes, including the second tumour-associated member, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16790; product specifications from Assay Genie datasheets.